annual EBITDA:
-$1.11B-$292.00M(-35.86%)Summary
- As of today (August 31, 2025), ROIV annual EBITDA is -$1.11 billion, with the most recent change of -$292.00 million (-35.86%) on March 31, 2025.
- During the last 3 years, ROIV annual EBITDA has fallen by -$195.57 million (-21.47%).
- ROIV annual EBITDA is now -35.86% below its all-time high of -$814.35 million, reached on March 31, 2024.
Performance
ROIV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$283.82M-$242.00K(-0.09%)Summary
- As of today (August 31, 2025), ROIV quarterly EBITDA is -$283.82 million, with the most recent change of -$242.00 thousand (-0.09%) on June 1, 2025.
- Over the past year, ROIV quarterly EBITDA has dropped by -$76.08 million (-36.63%).
- ROIV quarterly EBITDA is now -126.69% below its all-time high of -$125.20 million, reached on March 31, 2022.
Performance
ROIV quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$1.18B-$76.08M(-6.88%)Summary
- As of today (August 31, 2025), ROIV TTM EBITDA is -$1.18 billion, with the most recent change of -$76.08 million (-6.88%) on June 1, 2025.
- Over the past year, ROIV TTM EBITDA has dropped by -$349.84 million (-42.02%).
- ROIV TTM EBITDA is now -223.37% below its all-time high of -$365.67 million, reached on March 31, 2021.
Performance
ROIV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ROIV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -35.9% | -36.6% | -42.0% |
| 3 y3 years | -21.5% | -0.5% | +11.5% |
| 5 y5 years | - | +22.4% | -223.4% |
ROIV EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -35.9% | at low | -40.7% | +17.2% | -42.0% | +11.5% |
| 5 y | 5-year | -35.9% | at low | -126.7% | +58.5% | -223.4% | +18.4% |
| alltime | all time | -35.9% | at low | -126.7% | +58.5% | -223.4% | +18.4% |
ROIV EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$283.82M(+0.1%) | -$1.18B(+6.9%) |
| Mar 2025 | -$1.11B(+35.9%) | -$283.58M(+4.1%) | -$1.11B(+7.7%) |
| Dec 2024 | - | -$272.44M(-20.5%) | -$1.03B(+5.5%) |
| Sep 2024 | - | -$342.63M(+64.9%) | -$973.59M(+16.9%) |
| Jun 2024 | - | -$207.74M(+1.4%) | -$832.64M(-5.5%) |
| Mar 2024 | -$814.35M(-22.5%) | -$204.78M(-6.2%) | -$881.35M(-2.4%) |
| Dec 2023 | - | -$218.44M(+8.3%) | -$903.22M(-5.7%) |
| Sep 2023 | - | -$201.68M(-21.4%) | -$958.15M(-7.2%) |
| Jun 2023 | - | -$256.45M(+13.1%) | -$1.03B(-2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | -$1.05B(+15.4%) | -$226.66M(-17.1%) | -$1.06B(+10.6%) |
| Dec 2022 | - | -$273.36M(-0.8%) | -$956.57M(+3.1%) |
| Sep 2022 | - | -$275.69M(-2.3%) | -$927.86M(-30.6%) |
| Jun 2022 | - | -$282.31M(+125.5%) | -$1.34B(+10.6%) |
| Mar 2022 | -$910.77M(+1.7%) | -$125.20M(-48.8%) | -$1.21B(-16.6%) |
| Dec 2021 | - | -$244.65M(-64.3%) | -$1.45B(+20.3%) |
| Sep 2021 | - | -$684.43M(+343.3%) | -$1.20B(+131.6%) |
| Jun 2021 | - | -$154.39M(-57.8%) | -$520.06M(+42.2%) |
| Mar 2021 | -$895.74M | -$365.67M | -$365.67M |
FAQ
- What is Roivant Sciences Ltd. annual EBITDA?
- What is the all time high annual EBITDA for Roivant Sciences Ltd.?
- What is Roivant Sciences Ltd. annual EBITDA year-on-year change?
- What is Roivant Sciences Ltd. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Roivant Sciences Ltd.?
- What is Roivant Sciences Ltd. quarterly EBITDA year-on-year change?
- What is Roivant Sciences Ltd. TTM EBITDA?
- What is the all time high TTM EBITDA for Roivant Sciences Ltd.?
- What is Roivant Sciences Ltd. TTM EBITDA year-on-year change?
What is Roivant Sciences Ltd. annual EBITDA?
The current annual EBITDA of ROIV is -$1.11B
What is the all time high annual EBITDA for Roivant Sciences Ltd.?
Roivant Sciences Ltd. all-time high annual EBITDA is -$814.35M
What is Roivant Sciences Ltd. annual EBITDA year-on-year change?
Over the past year, ROIV annual EBITDA has changed by -$292.00M (-35.86%)
What is Roivant Sciences Ltd. quarterly EBITDA?
The current quarterly EBITDA of ROIV is -$283.82M
What is the all time high quarterly EBITDA for Roivant Sciences Ltd.?
Roivant Sciences Ltd. all-time high quarterly EBITDA is -$125.20M
What is Roivant Sciences Ltd. quarterly EBITDA year-on-year change?
Over the past year, ROIV quarterly EBITDA has changed by -$76.08M (-36.63%)
What is Roivant Sciences Ltd. TTM EBITDA?
The current TTM EBITDA of ROIV is -$1.18B
What is the all time high TTM EBITDA for Roivant Sciences Ltd.?
Roivant Sciences Ltd. all-time high TTM EBITDA is -$365.67M
What is Roivant Sciences Ltd. TTM EBITDA year-on-year change?
Over the past year, ROIV TTM EBITDA has changed by -$349.84M (-42.02%)